Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 9, 2024–
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, February 29, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.

Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations.

Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantumsi.supremeclients.com or follow us on LinkedIn or X (formerly Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240209064230/en/

Investors

Jeff Keyes, Chief Financial Officer

[email protected]

Media

Katherine Atkinson, SVP of Commercial Marketing

[email protected]

Source: Quantum-Si Incorporated